BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22288135)

  • 1. [Possibilities of using magnetic resonance imaging-transrectal ultrasound fusion in the diagnosis of recurrent prostate cancer].
    Kapustin VV
    Vestn Rentgenol Radiol; 2011; (3):53-6. PubMed ID: 22288135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
    Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
    Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
    Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
    Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion.
    Fiard G; Hohn N; Descotes JL; Rambeaud JJ; Troccaz J; Long JA
    Urology; 2013 Jun; 81(6):1372-8. PubMed ID: 23540865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy.
    Singh AK; Kruecker J; Xu S; Glossop N; Guion P; Ullman K; Choyke PL; Wood BJ
    BJU Int; 2008 Apr; 101(7):841-5. PubMed ID: 18070196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric magnetic resonance imaging-transrectal ultrasound fusion-assisted biopsy for the diagnosis of local recurrence after radical prostatectomy.
    Muller BG; Kaushal A; Sankineni S; Lita E; Hoang AN; George AK; Rais-Bahrami S; Kruecker J; Yan P; Xu S; de la Rosette JJ; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    Urol Oncol; 2015 Oct; 33(10):425.e1-425.e6. PubMed ID: 26259666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy.
    Parivar F; Hricak H; Shinohara K; Kurhanewicz J; Vigneron DB; Nelson SJ; Carroll PR
    Urology; 1996 Oct; 48(4):594-9. PubMed ID: 8886066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transrectal ultrasound versus magnetic resonance imaging for detection of rectal wall invasion by prostate cancer.
    Leibovici D; Kamat AM; Do KA; Pettaway CA; Ng CS; Evans RB; Rodriguez-Bigas M; Skibber J; Wang X; Pisters LL
    Prostate; 2005 Jan; 62(1):101-4. PubMed ID: 15389800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of dynamic contrast-enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: correlation with transrectal ultrasound and pathological findings.
    Kara T; Akata D; Akyol F; Karçaaltıncaba M; Özmen M
    Diagn Interv Radiol; 2011 Mar; 17(1):38-43. PubMed ID: 20703995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of complications rates between multiparametric magnetic resonance imaging-transrectal ultrasound (TRUS) fusion and systematic TRUS prostatic biopsies.
    Queiroz MRG; Falsarella PM; Mariotti GC; Lemos GC; Baroni RH; Mussi TC; Garcia RG
    Abdom Radiol (NY); 2019 Feb; 44(2):732-738. PubMed ID: 30255444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor--correlation with biopsy findings.
    Rouvière O; Valette O; Grivolat S; Colin-Pangaud C; Bouvier R; Chapelon JY; Gelet A; Lyonnet D
    Urology; 2004 May; 63(5):922-7. PubMed ID: 15134982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative evaluation of the efficiency of different magnetic resonance imaging procedures in the recognition of local recurrence of prostate cancer: preliminary results].
    Kapustin VV; Gromov AI; Koshurnikov DS
    Vestn Rentgenol Radiol; 2012; (5):48-51. PubMed ID: 23516885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of MRI-TRUS fusion versus cognitive registration accuracy for MRI-targeted, TRUS-guided prostate biopsy.
    Cool DW; Zhang X; Romagnoli C; Izawa JI; Romano WM; Fenster A
    AJR Am J Roentgenol; 2015 Jan; 204(1):83-91. PubMed ID: 25539241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.
    Steurer S; Rico SD; Simon R; Minner S; Tsourlakis MC; Krech T; Koop C; Graefen M; Heinzer H; Adam M; Huland H; Schlomm T; Sauter G; Lumiani A
    BJU Int; 2017 Sep; 120(3):365-376. PubMed ID: 28295933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
    Sciarra A; Panebianco V; Salciccia S; Osimani M; Lisi D; Ciccariello M; Passariello R; Di Silverio F; Gentile V
    Eur Urol; 2008 Sep; 54(3):589-600. PubMed ID: 18226441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer.
    Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S
    BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elastic Versus Rigid Image Registration in Magnetic Resonance Imaging-transrectal Ultrasound Fusion Prostate Biopsy: A Systematic Review and Meta-analysis.
    Venderink W; de Rooij M; Sedelaar JPM; Huisman HJ; Fütterer JJ
    Eur Urol Focus; 2018 Mar; 4(2):219-227. PubMed ID: 28753777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technique for a hybrid system of real-time transrectal ultrasound with preoperative magnetic resonance imaging in the guidance of targeted prostate biopsy.
    Ukimura O; Hirahara N; Fujihara A; Yamada T; Iwata T; Kamoi K; Okihara K; Ito H; Nishimura T; Miki T
    Int J Urol; 2010 Oct; 17(10):890-3. PubMed ID: 20812938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.